Less-invasive fascia-preserving surgery for abdominal wall desmoid

Abstract The mainstay of treatment for desmoid has been shifted to active surveillance (AS). However, surgery is still being performed on abdominal wall desmoid with a wide surgical margin. The purposes of this study are to clarify the treatment results of less-invasive, fascia preserving surgery fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoshihiro Nishida, Shunsuke Hamada, Tomohisa Sakai, Kan Ito, Kunihiro Ikuta, Hiroshi Urakawa, Hiroshi Koike, Shiro Imagama
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bb8cc918e08145e3b56e847b29781fce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb8cc918e08145e3b56e847b29781fce
record_format dspace
spelling oai:doaj.org-article:bb8cc918e08145e3b56e847b29781fce2021-12-02T18:51:07ZLess-invasive fascia-preserving surgery for abdominal wall desmoid10.1038/s41598-021-98775-22045-2322https://doaj.org/article/bb8cc918e08145e3b56e847b29781fce2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98775-2https://doaj.org/toc/2045-2322Abstract The mainstay of treatment for desmoid has been shifted to active surveillance (AS). However, surgery is still being performed on abdominal wall desmoid with a wide surgical margin. The purposes of this study are to clarify the treatment results of less-invasive, fascia preserving surgery for patients with abdominal wall desmoid, and to propose a new treatment modality. Since 2009, 34 patients with abdominal desmoid have been treated in our institution. Among them, as a final treatment modality, 15 (44%) were successful with AS, 15 were subjected to less-invasive surgery, and 4 methotrexate and vinblastine treatment. The clinical results of less-invasive surgery were clarified. In the surgical group, although the surgical margin was all microscopic positive (R1), only one patient (6.7%), who has the S45F mutation type of CTNNB1, showed recurrence, at a mean follow-up of 45 months. There were no patients with familial adenomatous polyposis (FAP)-related desmoid in this cohort. Only two patients (13%) required fascia lata patch reconstruction after removal of the tumor. In patients with non FAP-related abdominal wall desmoid, less-invasive, fascia preserving surgery is recommended as a favorable option as active treatment. Based on the results of this study, multi-institutional further research is warranted with an increased number of patients.Yoshihiro NishidaShunsuke HamadaTomohisa SakaiKan ItoKunihiro IkutaHiroshi UrakawaHiroshi KoikeShiro ImagamaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yoshihiro Nishida
Shunsuke Hamada
Tomohisa Sakai
Kan Ito
Kunihiro Ikuta
Hiroshi Urakawa
Hiroshi Koike
Shiro Imagama
Less-invasive fascia-preserving surgery for abdominal wall desmoid
description Abstract The mainstay of treatment for desmoid has been shifted to active surveillance (AS). However, surgery is still being performed on abdominal wall desmoid with a wide surgical margin. The purposes of this study are to clarify the treatment results of less-invasive, fascia preserving surgery for patients with abdominal wall desmoid, and to propose a new treatment modality. Since 2009, 34 patients with abdominal desmoid have been treated in our institution. Among them, as a final treatment modality, 15 (44%) were successful with AS, 15 were subjected to less-invasive surgery, and 4 methotrexate and vinblastine treatment. The clinical results of less-invasive surgery were clarified. In the surgical group, although the surgical margin was all microscopic positive (R1), only one patient (6.7%), who has the S45F mutation type of CTNNB1, showed recurrence, at a mean follow-up of 45 months. There were no patients with familial adenomatous polyposis (FAP)-related desmoid in this cohort. Only two patients (13%) required fascia lata patch reconstruction after removal of the tumor. In patients with non FAP-related abdominal wall desmoid, less-invasive, fascia preserving surgery is recommended as a favorable option as active treatment. Based on the results of this study, multi-institutional further research is warranted with an increased number of patients.
format article
author Yoshihiro Nishida
Shunsuke Hamada
Tomohisa Sakai
Kan Ito
Kunihiro Ikuta
Hiroshi Urakawa
Hiroshi Koike
Shiro Imagama
author_facet Yoshihiro Nishida
Shunsuke Hamada
Tomohisa Sakai
Kan Ito
Kunihiro Ikuta
Hiroshi Urakawa
Hiroshi Koike
Shiro Imagama
author_sort Yoshihiro Nishida
title Less-invasive fascia-preserving surgery for abdominal wall desmoid
title_short Less-invasive fascia-preserving surgery for abdominal wall desmoid
title_full Less-invasive fascia-preserving surgery for abdominal wall desmoid
title_fullStr Less-invasive fascia-preserving surgery for abdominal wall desmoid
title_full_unstemmed Less-invasive fascia-preserving surgery for abdominal wall desmoid
title_sort less-invasive fascia-preserving surgery for abdominal wall desmoid
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bb8cc918e08145e3b56e847b29781fce
work_keys_str_mv AT yoshihironishida lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT shunsukehamada lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT tomohisasakai lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT kanito lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT kunihiroikuta lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT hiroshiurakawa lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT hiroshikoike lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
AT shiroimagama lessinvasivefasciapreservingsurgeryforabdominalwalldesmoid
_version_ 1718377468822290432